Anti-beta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards.
about
Autoantibodies associated with rheumatic diseases.Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries.Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.Significance of K(L/V)WX(I/L/V)P Epitope of the B2Gpi in Its (Patho)Physiologic Function.Antiphospholipid antibodies: laboratory and pathogenetic aspects.Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value.Optimization of unnicked β2-glycoprotein I and high avidity anti-β2-glycoprotein I antibodies isolation.Alteration of antibody specificity during isolation and storage.Rational Laboratory Diagnostics of Antiphospholipid Antibodies: Anti-Cardiolipin, Anti-β2-Glycoprotein I, Anti-Prothrombin and Anti-Annexin V Antibodies.Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I.Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine.
P2860
Q34249566-41259923-185F-4A33-9D02-417790253077Q35167094-57E1282F-B688-47FD-9266-D08FA153683AQ35419865-6DE09371-D5D3-4EC6-9FB6-51EBB9175251Q35553532-FAE31841-2F9D-43AE-B4FA-8A2F58367ECAQ36147646-F179F4B3-44BB-4C27-A080-FB0281813B01Q36799474-F6B9B545-8B57-4F49-8BF6-DF8E703D624DQ37244052-82C1D6B7-9054-4362-9D95-BB6CAAE5BB16Q37704570-D4A6C5C6-C655-449F-81C4-786733BB429AQ39715020-2A0E5459-90B3-4C6E-B189-C47627127C27Q42378680-4F8BBDCA-86B0-4630-94FB-077AE9586FA5Q43172230-F9914CC5-B51B-4CF5-9E07-15CA2EDB2BC7Q47829847-D4A6B3BF-AFC6-42AC-8D5B-2EEBCB4F7940Q51836286-BA4B5859-44E1-4586-9D73-F2AE2A1C4CBC
P2860
Anti-beta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Anti-beta2-glycoprotein I ELIS ...... sible international standards.
@en
Anti-beta2-glycoprotein I ELIS ...... sible international standards.
@nl
type
label
Anti-beta2-glycoprotein I ELIS ...... sible international standards.
@en
Anti-beta2-glycoprotein I ELIS ...... sible international standards.
@nl
prefLabel
Anti-beta2-glycoprotein I ELIS ...... sible international standards.
@en
Anti-beta2-glycoprotein I ELIS ...... sible international standards.
@nl
P2093
P2860
P356
P1476
Anti-beta2-glycoprotein I ELIS ...... sible international standards.
@en
P2093
P2860
P304
P356
10.1515/CCLM.2000.111
P577
2000-08-01T00:00:00Z